Activity

Study Shows Mepolizumab to Be a Safe and Effective Long-Term Treatment Option for Severe Asthma

The Asthma and Allergy Foundation of America is sharing this press release from GlaxoSmithKline to bring you the latest research news quickly. [PRESS RELEASE] Nucala (mepolizumab) study reports long-term safety data, consistent exacerbation reduction and improved asthma control New study showed one third of patients had no exacerbations on long-term treatment with Nucala GlaxoSmithKline plc (GSK) today presented new data from the longest study of an anti-IL5 biologic treatment in severe...

Three Bills Could Have a Big Impact on People With Asthma and Allergies

May is National Asthma and Allergy Awareness Month . During this month, our community seeks to raise greater awareness with family, friends, coworkers and others about what it is like to live with asthma and allergies. It’s also a good time to engage with your elected officials in Congress about several pieces of legislation that improve access to asthma and allergy treatments and medicines, and protect the rights of our patient community. The Asthma and Allergy Foundation of America (AAFA)...

×
×
×
×